dUQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia eSchool of Mathematical Sciences, Queensland University of Technology, Brisbane, QLD, Australia ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced approval of a generic of Flovent hydrofluoroalkane inhalation aerosol for the maintenance ...

Phase 4 trial data demonstrate that switching to budesonide–formoterol relievers effectively lowers FeNO in asthma with high baseline inflammation. Budesonide–formoterol reliever therapy significantly ...

As new trial findings show significant reductions in paediatric asthma attacks from a budesonide-formoterol 2-in-1 reliever therapy, Professor Andy Bush speaks to Saša Janković about the system ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AIRSUPRA’s US Prescribing Information now includes clinically meaningful evidence from the BATURA study in patients with mild asthma. 1 The BATURA Phase IIIb trial, ...

A rescue inhaler that pairs a bronchodilator with an anti-inflammatory steroid just changed the conversation about “mild” asthma. In a recent study, Airsupra reduced the risk of a severe asthma attack ...